577 related items for PubMed ID: 15579802
1. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB.
J Clin Endocrinol Metab; 2004 Dec; 89(12):6348-57. PubMed ID: 15579802
[Abstract] [Full Text] [Related]
2. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J, Knappe UJ, Lüdecke DK.
Zentralbl Neurochir; 2003 Dec; 64(1):6-11. PubMed ID: 12582940
[Abstract] [Full Text] [Related]
3. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB, Turner HE, Adams CB, Wass JA.
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[Abstract] [Full Text] [Related]
4. Repeat transsphenoidal surgery for Cushing's disease.
Friedman RB, Oldfield EH, Nieman LK, Chrousos GP, Doppman JL, Cutler GB, Loriaux DL.
J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
[Abstract] [Full Text] [Related]
5. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B.
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[Abstract] [Full Text] [Related]
6. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER.
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[Abstract] [Full Text] [Related]
7. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[Abstract] [Full Text] [Related]
8. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
Abellán Galiana P, Fajardo Montañana C, Riesgo Suárez PA, Gómez Vela J, Escrivá CM, Lillo VR.
Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
[Abstract] [Full Text] [Related]
9.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
10. Does an analysis of the pulsatile secretion pattern of adrenocorticotropin and cortisol predict the result of transsphenoidal surgery in Cushing's disease?
Buchfelder M, Fahlbusch R, Wentzlaff-Eggebert H, Brabant G, Stalla GK, Müller OA.
J Clin Endocrinol Metab; 1993 Sep; 77(3):720-4. PubMed ID: 8396575
[Abstract] [Full Text] [Related]
11. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F, Tatai S, Aouali R, Semrouni M, Derome P, Chitour F, Benmiloud M.
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[Abstract] [Full Text] [Related]
12. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.
Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH.
J Neurosurg; 2003 May; 98(5):967-73. PubMed ID: 12744355
[Abstract] [Full Text] [Related]
13. Risk factors and long-term outcome in pituitary-dependent Cushing's disease.
Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M.
J Clin Endocrinol Metab; 1996 Jul; 81(7):2647-52. PubMed ID: 8675592
[Abstract] [Full Text] [Related]
14. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group.
Bochicchio D, Losa M, Buchfelder M.
J Clin Endocrinol Metab; 1995 Nov; 80(11):3114-20. PubMed ID: 7593411
[Abstract] [Full Text] [Related]
15. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T, Tsushima T, Hizuka N, Odagiri E, Murata Y, Suda T, Takano K.
Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
[Abstract] [Full Text] [Related]
16. Cushing's disease resulting from pituitary corticotrophic microadenoma. Treatment results from transsphenoidal microsurgery and gamma knife radiosurgery.
Laws ER, Reitmeyer M, Thapar K, Vance ML.
Neurochirurgie; 2002 May; 48(2-3 Pt 2):294-9. PubMed ID: 12058134
[Abstract] [Full Text] [Related]
17. Intracavernous sinus ectopic adrenocorticotropin-secreting tumours causing therapeutic failure in transsphenoidal surgery for Cushing's disease.
Ohnishi T, Arita N, Yoshimine T, Mori S.
Acta Neurochir (Wien); 2000 May; 142(8):855-64. PubMed ID: 11086823
[Abstract] [Full Text] [Related]
18. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.
Shimon I, Ram Z, Cohen ZR, Hadani M.
Neurosurgery; 2002 Jul; 51(1):57-61; discussion 61-2. PubMed ID: 12182435
[Abstract] [Full Text] [Related]
19. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.
Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER.
J Clin Endocrinol Metab; 2008 Feb; 93(2):358-62. PubMed ID: 18056770
[Abstract] [Full Text] [Related]
20. Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood.
Leinung MC, Kane LA, Scheithauer BW, Carpenter PC, Laws ER, Zimmerman D.
J Clin Endocrinol Metab; 1995 Aug; 80(8):2475-9. PubMed ID: 7629245
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
